EFFICACY OF OMALIZUMAB TREATMENT FOR PATIENTS WITH CHRONIC SPONTANEOUS URTICARIA
Journal Title: Pulmonologija ir alergologija - Year 2018, Vol 2, Issue 1
Abstract
Background. Chronic spontaneous urticaria is defined as itchy hives, lasting for 6 and more weeks, with or without angioedema. Part of the patients do not have a response to a standard therapy with H1 antihistamines even taking four times their licensed doses. Omalizumab is a monoclonal anti-IgE antibody, recommended as a most effective III step treatment for chronic, antihistamines resistant spontaneous urticaria. Aim. To evaluate effectiveness of omalizumab in chronic spontaneous urticaria. Methods. In this article we present aretrospective analysis of 22 patients with an antihistamine resistant chronic spontaneous urticaria, treated with omalizumab in Department of Immunology and Allergology of Hospital of Lithuania University of Health Sciences Kauno klinikos. Activity of the disease was evaluated using urticaria activity score (UAS7) before and after treatment with omalizumab. Results.Reduction of chronic urticaria symptoms (urticaria activity score decreased more than 50 percent) was observed in 18 patients (81.8%), seven patients (31.8%) had decreased symptoms after first injection of omalizumab, eight of the patients (47.1%) who had finished 6 month treatment course, had renewal of urticaria symptoms and the treatment was continued. Conclusion. Omalizumab markedly reduce urticaria activity in patients with antihistamine-resistant chronic spontaneous urticaria. Omalizumab did not lose effectiveness after its reintroduction in treatment of relapsed chronic spontaneous urticaria.
Authors and Affiliations
Margarita Paulauskaitė, Ieva Bajoriūnienė, Jūratė Staikūnienė, Edita Gasiūnienė, Simona Kašinskaitė, Brigita Šitkauskienė
Keywords
Related Articles
- EP ID EP502106
- DOI -
- Views 119
- Downloads 0
COMPREHENSIVE GENOMIC PROFILING IN DIAGNOSTIC OF LUNG CANCER
Diagnosis of lung cancer should be confirmed morphologically and TNM stage must be established. Now systemic treatment of lung cancer should be personalized on the basis on tumor molecular properties, specifically on tar...
LABORATORY DIAGNOSTICS FOR SYSTEMIC AUTOIMMUNE DISEASES WITH PULMONARY INVOLVEMENT
Most of the systemic autoimmune diseases are related to multiorgan involvement. As expected in such a disease, the entire pulmonary system is vulnerable to injury. In this article, we present systemic autoimmune diseases...
EXTRACELLULAR MATRIX AND ITS ROLE IN ASTHMA
Today, scientists have a lot of data about the extracellular matrix, but it's still underdeveloped the changes of pathogenesis in different illness. Therefore, the interaction between the structural cells of the cells an...
THE BENEFIT OF SINGLE INHALER TRIPLE THERAPY IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Chronic obstructive pulmonary disease (COPD) is characterised by persistent obstruction of lung airflow, determinating respiratory symptoms, which increase while disease is progressing and exacerbations are...
LUNG CANCER IMMUNOTHERAPY
The immune system plays a crucial role in protecting the body against cancer by recognizing and destroying cells it perceives as foreign. Cancer immunity strategies aim to restore immunity sy...